Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO
Orwoll, E.; Stubbe Teglbjaerg, Ch; Langdahl, B. et al.
2011 • In Journal of Bone and Mineral Research, 26 (S1), p. 511
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/108955
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
A Phase 3 Study of the Efficacy and Safety of Denosumab in Men With Low.pdf
Publisher postprint (475.5 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
General & internal medicine
Author, co-author :
Orwoll, E.
Stubbe Teglbjaerg, Ch
Langdahl, B.
Chapurlat, R.
Czerwinski, E.
Kenkler, D. L.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Kivitz, A.
Lewieck, E. M.
Miller, P.
Bolognese, M. A.
Bone, H. G.
Ljunggren, O.
Abrahamsen, B.
Yan, Y-Ch
Grauer, A.
Libanati, C.
Hall, J. W.
Boonen, S.
More authors (9 more) Less
Language :
English
Title :
A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO
Publication date :
2011
Event name :
ASBMR 2011 Annual Meeting
Event organizer :
The American Society for Bone and Mineral Research
Event place :
San Diego, California, United States
Event date :
Du 16 au 20 septembre 2011
Audience :
International
Journal title :
Journal of Bone and Mineral Research
ISSN :
0884-0431
eISSN :
1523-4681
Publisher :
American Society for Bone and Mineral Research, Washington, United States - District of Columbia
Volume :
26
Issue :
S1
Pages :
511
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 20 January 2012

Statistics

Number of views
108 (2 by ULiège)
Number of downloads
1 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi